Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENNY PCI: Enoxaparin Infusion in STEMI
NCT03146858Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Aug 2017
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of enoxaparin in ST elevation myocardial infarction (STEMI), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: anti Xa activity change at 6 hours. Started Aug 2017; status: completed.
02
Drugs
enoxaparin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03146858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03146858.